Germany
April 2, 2014
Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, announces that it is combining its competencies to provide the most complete suite of genomics services in the market. Eurofins MWG Operon, a pioneer and key provider of genomic services, and Eurofins Medigenomix, the Group’s competence center for applied solutions in DNA & RNA analysis, are being brought together under the new global brand name Eurofins Genomics.
The new brand represents the genomics division of the Eurofins Scientific Group, and consolidates its market presence as a provider of full genomic services in various market segments. Eurofins Genomics operates leading R&D and production sites in the USA (Huntsville, AL and Louisville, KY), Germany (Ebersberg), India (Bangalore) and Japan (Tokyo).
Eurofins Genomics services are tailored for pharma, diagnostics, agriculture, food, biotechnology and research applications worldwide. Together with the international laboratory network of the Eurofins Group, Eurofins Genomics has an outstanding team of experts utilizing a broad range of state-of-the-art technologies to provide the highest quality of service in DNA & RNA oligonucleotides, custom DNA and next generation sequencing, gene synthesis and molecular biology, as well as genotyping and gene expression.
Comment from Bruno Poddevin, Senior Vice President Eurofins Genomics: “After years of continuous growth within the Eurofins Scientific network, I am extremely happy to align our traditional brands, “MWG”, “Operon” and “Medigenomix”, under a single brand which is synonymous with our commitment to be first-in-class provider of genomic services. This underlines our goal to strengthen our global position as the leading supplier of applied genomics solutions in the future”.
Topics
Species
